Written and peer-reviewed by physicians—but use at your own risk. Read our disclaimer.

banner image

amboss

Trusted medical answers—in seconds.

Get access to 1,000+ medical articles with instant search
and clinical tools.

Try free for 5 days

Diseases of the retina

Last updated: January 15, 2021

Summarytoggle arrow icon

The retina, which contains the first three neurons of the visual pathway, mediates the conversion of light stimuli into nerve impulses. Diseases of the retina may lead to visual impairment, visual field loss, and more complex disorders such as metamorphopsia (distorted vision) and clouding. Ophthalmoscopy is the preferred diagnostic method for identifying retinal diseases, but depending on the suspected disorder, other methods such as fluorescein angiography and optical coherence tomography (OCT) may be appropriate.

  • Color blindness or dyschromatopsia: altered color perception; congenital or acquired (e.g., optic neuropathy due to ethambutol)
    • Congenital; color perception disorders (especially red-green color vision deficiency; ) are very common and occur mostly in men.
    • Affected individuals are generally unaware of their own color-perception disorders.
    • Dichromacy: Only two of the three types of cones in the retina are fully functional.
      • Types
        • Deuteranomaly: green color deficiency (very common: ∼ 5% of the male population)
        • Deuteranopia: green color blindness (∼ 1% of the male population)
        • Protanomaly: red color deficiency (∼ 1% of the male population)
        • Protanopia: red color blindness (∼ 1% of the male population)
        • Tritanomaly: blue-yellow color weakness (very rare)
        • Tritanopia: blue-yellow color blindness (very rare)
      • Clinical features: difficulties distinguishing colors from one another
      • Diagnosis
        • Ishihara color test: set of color-dotted plates used to diagnose deuteranopia and protanopia
        • Anomaloscope: instrument used to diagnose quantitative and qualitative defects in color perception
  • Achromatism: complete color blindness (very rare)

References:[1][2][3]

Central serous retinopathy (central serous chorioretinopathy)

  • Definition: serous retinal detachment at the posterior pole of the eyeball (at the macula or in the perimacular region) due to a defect in the pigment epithelium
  • Pathophysiology: defect in the area of Bruch's membrane/pigment epithelium → fluid leakage from the sclera into the subretinal space → serous retinal detachment
  • Etiology
  • Epidemiology
    • Mostly affects men 20–45 years of age
  • Clinical features
    • Hyperopia
    • Metamorphopsia (distorted vision)
    • Patients perceive images as smaller than they are
    • Relative scotoma (perception of a gray area or shadow in the central field of vision)
  • Diagnostics
    • Ophthalmoscopy: roundish detachment of the central retina
    • Fluorescein angiography: an imaging procedure in which fluorescent dye (fluorescein) is injected intravenously in order to highlight retinal vessels, which are then photographed.
    • Optical coherence tomography (OCT)
  • Treatment
    • Often heals spontaneously
    • Stress reduction
    • Rarely: laser coagulation (in extramacular localization), photodynamic therapy

Macular hole

Age-related macular degeneration

See age-related macular degeneration.

Retinal detachment

See retinal detachment.

References:[4]

Retinitis pigmentosa

Stargardt's disease

Best disease (vitelliform macular dystrophy)

  • Definition: juvenile macular dystrophy, autosomal dominant inheritance
  • Clinical features
    • Chronic progressive visual impairment; onset typically between 4–10 years
    • People often have vision of approx. 20/40
  • Diagnostics
  • Treatment: No causal therapy is known.
  • Prognosis: Some patients may not have visual deterioration beyond 20/40. However, the deterioration may progress after age 40.

Disorders covered in other LCs

Coats disease (exudative retinopathy)

Retinopathy of prematurity (ROP)

  • Definition: disease of the retina with abnormal vessel proliferations that affects preterm infants
  • Pathophysiology
  • Risk factors
  • Diagnostics: screening of all premature babies that are at risk for developing ROP
    • Indications
    • Timing of examinations
      • First examination 6 weeks postnatally (in cases of prematurity, screening starts at the 30th week of gestation)
      • Follow-up depending upon findings or state of the ocular fundus
    • The examination of the ocular fundus assesses the following:
      • Vascularization of the peripheral retina
      • Demarcation line between vascularized and nonvascularized retina
      • Extraretinal vessel formations
      • Formation of membranes and distortion/detachment of the retina
      • Plus disease: increased tortuosity, exudation, hemorrhage
    • Discontinuation of follow-up screening
  • Treatment
    • In early stages of the disease: no treatment, but regular follow-up
    • In advanced stages: laser coagulation therapy may be indicated
    • In onset of retinal detachment: vitrectomy may be indicated
  • Complications
  • Prevention
    • Monitoring oxygen pressures
    • Regular fundoscopic exams to prevent delays in necessary treatments

  1. Small L, Suh DW. Juvenile Retinoschisis. Juvenile Retinoschisis. New York, NY: WebMD. http://emedicine.medscape.com/article/1225857. Updated: May 2, 2017. Accessed: May 18, 2017.
  2. A Quick Introduction to Colorblindness. http://wearecolorblind.com/article/a-quick-introduction-to-color-blindness/. Updated: January 10, 2012. Accessed: May 18, 2017.
  3. Color Vision Deficiency. https://ghr.nlm.nih.gov/condition/color-vision-deficiency. Updated: December 12, 2017. Accessed: December 16, 2017.
  4. Álvaro L, Moreira H, Lillo J, Franklin A. Color preference in red–green dichromats. Proceedings of the National Academy of Sciences. 2015; 112 (30): p.9316-9321. doi: 10.1073/pnas.1502104112 . | Open in Read by QxMD